FDA: No Such Thing as No Drug Risk

03:41 | Jason Lopez | Sep 12th, 2006 1:38pm |

The U.S. Food and Drug Administration says it is a constant balancing act to determine how much risk to consumers is acceptable in the drug approval process. No risk would result in few drugs coming to market. Some risk allows more. But Dr. Steve Galson, director of the FDA’s Center for Drug Evaluation and Research, tells PodTech’s Jason Lopez that the fate of drug companies — including startups that must get approval to stay in business — are not part of the Administration’s consideration. They spoke at Health Care Innovations 2006.

Tags: Food and Drug Administration, Steve Galson

This entry was posted on Tuesday, September 12th, 2006 at 1:38 pm and is filed under PodTech, Dow Jones VentureWire, Events, Technology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Post to your WordPress.com blog »